• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

DART improves treatment decision-making for patients with chronic kidney disease

byAndrew LeeandKiera Liblik
January 9, 2023
in Chronic Disease, Nephrology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Patients with chronic kidney disease (CKD) who used Decision-Aid for Renal Therapy (DART) demonstrated improved decision quality compared to those receiving care as usual.

2. Patients who used DART had increased knowledge regarding treatment options compared to those who received care as usual. 

Evidence Rating Level: 1 (Excellent)

Study Rundown: Individuals with advanced CKD face decisions regarding kidney replacement therapy, which are often life-long interventions. Patients require knowledge about their prognosis and treatment options to make informed decisions that are aligned with their personal values. DART is an educational tool developed for patients with CKD. The present study evaluated decision-making in patients with CKD with and without the DART tool. Decisional conflict scores were significantly improved for individuals in the DART group at both three and six-month follow-ups. Improvements were also seen in the DART group across various subscales of the decisional conflict scale. These results were consistent across subgroups including site, sex, race, education, health literacy, diabetes status, and kidney function. Patient knowledge was improved for both control and DART groups and these improvements persisted at 6 and 18-month follow-ups. Fewer individuals were “unsure” about treatment preferences over time in the DART group as compared to the control group. Treatment preferences were stable in both groups once they were established. The strength of this study is that multiple domains of decisional conflict, knowledge, and treatment preferences were examined. A limitation is the generalizability of the results, as the materials may not be accessible or comprehensible to those who are not proficient in English or have lower levels of literacy.

Click to read the study in AIM

Relevant Reading: Effects of dapagliflozin on hospitalizations in patients with chronic kidney disease: A post hoc analysis of DAPA-CKD

In-Depth [randomized controlled trial]: This multicenter, randomized control trial compared the effectiveness of DART to standard educational materials for improving decisional quality in CKD patients. The DART content included education modules on kidney failure, peritoneal dialysis, hemodialysis, renal transplant, medical management, and decision-making. Questions and prompts were written at a grade six reading level. The comparator intervention was a pamphlet from the National Kidney Foundation titled “Choosing a Treatment for Kidney Failure”. A total of 363 participants were randomized (180 to control and 183 to DART) and baseline characteristics between the two groups were balanced. Decisional conflict scores improved in the DART group at three- and six-month follow-up with mean differences of -7.9 (95% Confidence Interval [CI], -12.0 to -3.8) and -8.5 (95% CI, -13.0 to -3.9), respectively. As compared to the placebo group, patients in the DART group had knowledge improvement at three months (mean difference 9.0; 95% CI, 4.6 to 13.4), six months (mean difference, 9.4; 95% CI, 5.1 to 13.8), and 18 months (mean difference, 5.9; 95%CI, 1.4 to 10.3). Treatment preferences in the DART group changed from 58.5% “unsure” at baseline to 27.5%, 19.9%, 23.1%, and 13.9% at 3, 6, 12, and 18- month follow-ups, respectively. Preference for conservative management was increased from baseline (11.5%) in the DART group to 16.9% at three months and 19.9% at six months. Conservative management preferences were largely unchanged in the control group. In participants who initiated dialysis during the trial, 98% had treatment concordant to their last expressed preference before the initiation of dialysis. In summary, this study demonstrated that the DART tool improves decision-making and knowledge for patients with CKD.

RELATED REPORTS

Hydrochlorothiazide does not impact risk of kidney-stone recurrence

Nivolumab plus ipilimumab does not improve survival in post-nephrectomy patients with renal cell carcinoma

Symptom and viral relapse more common in COVID-19 patients without antiviral treatment

Image: PD

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: chronic diseasechronic kidney diseaseCKDDecision-Aid for Renal TherapynephrologyRenal dysfunctionshared decision-making
Previous Post

Dupilumab improves symptoms and increases remission rates in eosinophilic esophagitis

Next Post

Intensive outpatient prolonged exposure effective for combat related posttraumatic stress disorder

RelatedReports

Renal stones in women linked with increased risk of coronary heart disease
Nephrology

Hydrochlorothiazide does not impact risk of kidney-stone recurrence

March 22, 2023
Tenofovir disoprovil fumarate HIV prophylaxis linked with minimal kidney impact
Chronic Disease

Nivolumab plus ipilimumab does not improve survival in post-nephrectomy patients with renal cell carcinoma

March 21, 2023
Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children
Chronic Disease

Symptom and viral relapse more common in COVID-19 patients without antiviral treatment

March 21, 2023
Benefits of high-intensity surveillance following colorectal adenoma removal likely outweigh costs
Chronic Disease

Adenoma detection rate is inversely associated with post-colonoscopy colorectal cancer risk

March 20, 2023
Next Post
Mindfulness-based therapy associated with improvement in quality of life for PTSD patients

Intensive outpatient prolonged exposure effective for combat related posttraumatic stress disorder

Quick Take: Efficacy of short-term treatment of internet and computer game addiction

Religiosity may be protective against internet addiction

The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!

The Scan by 2 Minute Medicine®: The Genetics of Alzheimer's Disease, the Silent Killer, a Holiday Blizzard and an HIV Vaccine on the Horizon

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Stroke may be associated with sleep disturbances in adults
  • Transcarotid artery revascularization not associated with a significant difference in 30-day risk of stroke, death and myocardial infarction compared to carotid endarterectomy
  • Drinking characteristics in adolescence predict alcohol behaviors in early adulthood
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options